Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...
PharmTech

Integrating AI and Machine Learning in Drug Discovery and Development

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Plastics Today

AI, Machine Learning Accelerate Materials Research, Compress R&D Timelines

Two recent developments in artificial intelligence (AI) and machine learning have the potential to accelerate product development by streamlining materials research. Israel-based MaterialsZone, a ...
Nasdaq

Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer

DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...